Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ischemic Heart Disease

  Free Subscription

Articles published in
Ann Intern Med
    June 2021
  1. TANNER M
    In type 2 diabetes, SGLT2 inhibitors reduce all-cause, but not cardiovascular, mortality vs. GLP-1 RAs.
    Ann Intern Med. 2021 Jun 1. doi: 10.7326/ACPJ202106150.
    >> Share

    April 2021
  2. NEWTON SL, Yeh JS
    Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults.
    Ann Intern Med. 2021;174:582-583.
    >> Share

  3. CHOW EJ, O'Halloran A, Rolfes MA, Reed C, et al
    Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults.
    Ann Intern Med. 2021;174:583-584.
    >> Share

  4. SCHATTNER A
    Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults.
    Ann Intern Med. 2021;174:583.
    >> Share

    March 2021
  5. NANNA MG, Newby LK
    In coronary artery disease, PCI increases all-cause and cause-specific mortality compared with CABG.
    Ann Intern Med. 2021 Mar 2. doi: 10.7326/ACPJ202103160.
    >> Share

  6. BATES ER
    In patients with CAD, adding colchicine to evidence-based therapies reduces MACE without increasing adverse outcomes.
    Ann Intern Med. 2021;174:JC30.
    >> Share

  7. GIANNASI G, Nanni V, Nucci A, Perini AP, et al
    Acute ST-Segment Elevation From an Ingested Battery: A Case Report.
    Ann Intern Med. 2021;174:425-426.
    >> Share

    January 2021
  8. COHN JN
    Low-dose colchicine reduced risk for cardiovascular events in chronic coronary disease.
    Ann Intern Med. 2021 Jan 5. doi: 10.7326/ACPJ202101190.
    >> Share

    December 2020
  9. HICKS CW, Wang D, Matsushita K, Windham BG, et al
    Peripheral Neuropathy and All-Cause and Cardiovascular Mortality in U.S. Adults : A Prospective Cohort Study.
    Ann Intern Med. 2020 Dec 8. doi: 10.7326/M20-1340.
    >> Share

    October 2020
  10. BAVISHI C
    In ACS treated with drug-eluting stents and 3 mo of DAPT, ticagrelor monotherapy reduced clinical events at 1 y vs. DAPT.
    Ann Intern Med. 2020;173:JC43.
    >> Share

  11. NANNA MG, Granger CB
    In ACS, ticagrelor and prasugrel each reduce some ischemic events but increase major bleeding vs. clopidogrel.
    Ann Intern Med. 2020;173:JC44.
    >> Share

    September 2020
  12. RESTON JT, Buelt A, Donahue MP, Neubauer B, et al
    Interventions to Improve Statin Tolerance and Adherence in Patients at Risk for Cardiovascular Disease : A Systematic Review for the 2020 U.S. Department of Veterans Affairs and U.S. Department of Defense Guidelines for Management of Dyslipidemia.
    Ann Intern Med. 2020 Sep 22. doi: 10.7326/M20-4680.
    >> Share

  13. O'MALLEY PG, Arnold MJ, Kelley C, Spacek L, et al
    Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2020 Updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline.
    Ann Intern Med. 2020 Sep 22. doi: 10.7326/M20-4648.
    >> Share

  14. KELSEY MD, Newby LK
    In older patients with NSTE-ACS, clopidogrel safely reduced bleeding compared with ticagrelor at 1 year.
    Ann Intern Med. 2020;173:JC28.
    >> Share

  15. HOFFER EP
    In AF with recent ACS or PCI, apixaban improved 30-day outcomes vs. VKAs; aspirin effects varied vs. placebo.
    Ann Intern Med. 2020;173:JC29.
    >> Share

  16. ELGENDY IY
    In ACS, prasugrel reduces 30-day MACE and mortality vs. ticagrelor or clopidogrel; no differences for major bleeding.
    Ann Intern Med. 2020;173:JC27.
    >> Share

  17. D'ANCI KE, Tipton K, Hedden-Gross A, Rouse B, et al
    Effect of Intensive Blood Pressure Lowering on Cardiovascular Outcomes: A Systematic Review Prepared for the 2020 U.S. Department of Veterans Affairs/U.S. Department of Defense Guidelines.
    Ann Intern Med. 2020 Sep 1. doi: 10.7326/M20-2037.
    >> Share

    August 2020
  18. MACINTYRE CR
    Influenza Vaccine: Routine Secondary Prevention for Patients With Cardiovascular Disease?
    Ann Intern Med. 2020 Aug 25. doi: 10.7326/M20-5810.
    >> Share

  19. CHOW EJ, Rolfes MA, O'Halloran A, Anderson EJ, et al
    Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults : A Cross-sectional Study.
    Ann Intern Med. 2020 Aug 25. doi: 10.7326/M20-1509.
    >> Share

  20. BATES ER
    In stable coronary disease with moderate or severe ischemia, initial invasive therapy plus medical therapy did not improve CV outcomes at 3 years.
    Ann Intern Med. 2020;173:JC14.
    >> Share

  21. BATES ER
    Invasive therapy improved angina health status in patients with high-risk stable coronary disease and more frequent angina.
    Ann Intern Med. 2020;173:JC15.
    >> Share

  22. HERRINGTON WG, Staplin N
    In patients with coronary disease and CKD, adding an invasive strategy to MT did not improve outcomes.
    Ann Intern Med. 2020;173:JC16.
    >> Share

  23. HERRINGTON WG, Staplin N
    In patients with coronary disease and CKD, initial invasive therapy did not improve angina-related health status.
    Ann Intern Med. 2020;173:JC17.
    >> Share

    July 2020
  24. MERLI GJ, Weitz HH
    Web Exclusive. Annals Consult Guys - Coronary Artery Calcium Score: Chalk or Cheese?
    Ann Intern Med. 2020;173:CG1.
    >> Share

  25. MENICHELLI M, Neumann FJ, Ndrepepa G, Mayer K, et al
    Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes: Results From a Randomized Trial.
    Ann Intern Med. 2020 Jul 21. doi: 10.7326/M20-1806.
    >> Share

  26. CONEN D, Md PJD
    The Value of Large Randomized Trials of Two Active Interventions to Define the Optimal Treatment in Patients With Acute Coronary Syndrome.
    Ann Intern Med. 2020 Jul 21. doi: 10.7326/M20-4770.
    >> Share


  27. Correction: Annals Consult Guys - Preventing Coronary Disease in Rheumatoid Arthritis: Do Guidelines Apply?
    Ann Intern Med. 2020;173:79.
    >> Share

  28. KIM JH, Hammadah M, Vaccarino V, Quyyumi AA, et al
    High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia in Symptomatic Patients.
    Ann Intern Med. 2020;173:76-77.
    >> Share

  29. WALTER J, Mueller C
    High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia in Symptomatic Patients.
    Ann Intern Med. 2020;173:77.
    >> Share

    June 2020
  30. DUCEPPE E, Heels-Ansdell D, Devereaux PJ
    Preoperative N-Terminal Pro-B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery.
    Ann Intern Med. 2020;172:843.
    >> Share

  31. GUPTA N, Doshi R, Meghrajani V
    Preoperative N-Terminal Pro-B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery.
    Ann Intern Med. 2020;172:842.
    >> Share

  32. BHUDIA N, Bakhai A, Baumber R
    Preoperative N-Terminal Pro-B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery.
    Ann Intern Med. 2020;172:842-843.
    >> Share

  33. MURRAY H, Slaunwhite E
    Accelerated diagnostic algorithms with hs-cTn have >/= 92% sensitivity but lower specificity for diagnosing AMI.
    Ann Intern Med. 2020;172:JC71.
    >> Share

    May 2020
  34. FINUCANE TE
    Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status.
    Ann Intern Med. 2020;172:707.
    >> Share

  35. PARK S, Han K, Kim DK
    Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status.
    Ann Intern Med. 2020;172:707-708.
    >> Share

  36. VALLABHAJOSYULA S, Bell MR
    In unprotected left main CAD, revascularization with PCI and DES increased risk for MACCE vs CABG at 5 years.
    Ann Intern Med. 2020;172:JC55.
    >> Share

    April 2020
  37. BACH RG
    Low-dose colchicine after MI reduced a composite ischemic cardiovascular outcome vs placebo.
    Ann Intern Med. 2020;172:JC39.
    >> Share

    March 2020
  38. KLOECKER DE, Davies MJ, Khunti K, Zaccardi F, et al
    Uses and Limitations of the Restricted Mean Survival Time: Illustrative Examples From Cardiovascular Outcomes and Mortality Trials in Type 2 Diabetes.
    Ann Intern Med. 2020 Mar 24. pii: 2763641. doi: 10.7326/M19-3286.
    >> Share

  39. VALLURUPALLI M, MacFadyen JG, Glynn RJ, Thuren T, et al
    Effects of Interleukin-1beta Inhibition on Incident Anemia: Exploratory Analyses From a Randomized Trial.
    Ann Intern Med. 2020 Mar 24. pii: 2763494. doi: 10.7326/M19-2945.
    >> Share

  40. KHAN SU, Osman M, Khan MU, Khan MS, et al
    Dual Versus Triple Therapy for Atrial Fibrillation After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2020 Mar 17. pii: 2763089. doi: 10.7326/M19-3763.
    >> Share

  41. DOHERTY JU
    Combined Antiplatelet and Anticoagulant Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Navigating Between Scylla and Charybdis.
    Ann Intern Med. 2020 Mar 17. pii: 2763091. doi: 10.7326/M20-0572.
    >> Share

    January 2020
  42. RANASINGHE I, Hossain S, Ganesan A, Krumholz HM, et al
    Institutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation.
    Ann Intern Med. 2020;172:166-167.
    >> Share

  43. EMAMI M, Wong CX, Tu S, Sanders P, et al
    Institutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation.
    Ann Intern Med. 2020;172:166.
    >> Share

  44. SANTULLI G
    In AF and stable CAD, rivaroxaban reduced cardiovascular events and mortality more than rivaroxaban plus an antiplatelet.
    Ann Intern Med. 2020;172:JC6.
    >> Share

  45. HUDSON M
    In suspected AMI, an extended algorithm increased sensitivity and decreased specificity for predicting 30-day MACE.
    Ann Intern Med. 2020;172:JC11.
    >> Share

  46. RACO DL
    In ACS with planned invasive evaluation, prasugrel vs ticagrelor reduced a composite of death, MI, or stroke at 1 y.
    Ann Intern Med. 2020;172:JC5.
    >> Share

  47. RACO DL
    In stable CAD with type 2 diabetes, adding ticagrelor to aspirin reduced CV events but increased major bleeding.
    Ann Intern Med. 2020;172:JC4.
    >> Share

  48. CORNELL JE, Mulrow CD
    Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes.
    Ann Intern Med. 2020;172:75.
    >> Share

  49. MAYER M
    Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes.
    Ann Intern Med. 2020;172:74.
    >> Share

  50. KIVELA JM
    Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes.
    Ann Intern Med. 2020;172:73-74.
    >> Share

  51. BELL KJL, Semsarian C, Doust J
    Why We Might Not Need to Stress About Ruling Out Inducible Myocardial Ischemia.
    Ann Intern Med. 2020 Jan 7. pii: 2758510. doi: 10.7326/M19-3731.
    >> Share

  52. WALTER J, du Fay de Lavallaz J, Koechlin L, Zimmermann T, et al
    Using High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia in Symptomatic Patients: A Cohort Study.
    Ann Intern Med. 2020 Jan 7. pii: 2758509. doi: 10.7326/M19-0080.
    >> Share

    December 2019
  53. DUCEPPE E, Patel A, Chan MTV, Berwanger O, et al
    Preoperative N-Terminal Pro-B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery: A Cohort Study.
    Ann Intern Med. 2019 Dec 24. pii: 2758032. doi: 10.7326/M19-2501.
    >> Share

  54. QAMAR A, Bangalore S
    Biomarkers to Personalize Preoperative Cardiovascular Risk Stratification: Ready for Prime Time?
    Ann Intern Med. 2019 Dec 24. pii: 2758034. doi: 10.7326/M19-3718.
    >> Share


  55. Correction: Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes.
    Ann Intern Med. 2019 Dec 17. pii: 2757635. doi: 10.7326/L19-0721.
    >> Share

  56. DODSON JA, Hajduk AM, Geda M, Krumholz HM, et al
    Predicting 6-Month Mortality for Older Adults Hospitalized With Acute Myocardial Infarction: A Cohort Study.
    Ann Intern Med. 2019 Dec 10. pii: 2757402. doi: 10.7326/M19-0974.
    >> Share

  57. KAZI DS, Bibbins-Domingo K
    Accurately Predicting Cardiovascular Risk-and Acting on It.
    Ann Intern Med. 2019 Dec 10. pii: 2757420. doi: 10.7326/M19-3662.
    >> Share

  58. DOXEY R
    Stable Ischemic Heart Disease.
    Ann Intern Med. 2019;171:862-863.
    >> Share

    November 2019
  59. PARK S, Lee S, Kim Y, Lee Y, et al
    Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status: A Nationwide Population-Based Study of Approximately 10 Million Persons.
    Ann Intern Med. 2019 Nov 26. pii: 2756142. doi: 10.7326/M19-0563.
    >> Share


  60. Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status.
    Ann Intern Med. 2019 Nov 26. pii: 2756144. doi: 10.7326/P19-0016.
    >> Share

  61. CHESKIN LJ, Slavin M
    Review: No high-certainty evidence exists that nutritional supplements or diets affect cardiovascular outcomes.
    Ann Intern Med. 2019;171:JC50.
    >> Share

    October 2019
  62. MERLI GJ, Weitz HH
    Web Exclusive. Annals Consult Guys - Preventing Coronary Disease in Rheumatoid Arthritis: Do Guidelines Apply?
    Ann Intern Med. 2019;171:CG1.
    >> Share

  63. COHEN JB, Denker MG, Cohen DL, Townsend RR, et al
    Cardiovascular Events and Mortality in White Coat Hypertension.
    Ann Intern Med. 2019;171:603-604.
    >> Share

  64. ZHANG ZY, Asayama K, Franklin SS, Thijs L, et al
    Cardiovascular Events and Mortality in White Coat Hypertension.
    Ann Intern Med. 2019;171:602-603.
    >> Share

  65. BELLO NA, Miller EC, Cleary KL, Wapner R, et al
    Cases in Precision Medicine: A Personalized Approach to Stroke and Cardiovascular Risk Assessment in Women.
    Ann Intern Med. 2019 Oct 15. pii: 2753022. doi: 10.7326/M19-1601.
    >> Share

  66. BATES ER
    In patients with suspected AMI and LBBB, algorithms based on ECG and troponin data were tested to rule MI in or out.
    Ann Intern Med. 2019;171:JC47.
    >> Share

  67. BATES ER
    In suspected MI without ST elevation, a risk tool including hs-cTnI or hs-cTnT predicted diagnosis and 30-d outcomes.
    Ann Intern Med. 2019;171:JC46.
    >> Share

    September 2019
  68. SELAK V, Jackson R, Poppe K, Wu B, et al
    Personalized Prediction of Cardiovascular Benefits and Bleeding Harms From Aspirin for Primary Prevention: A Benefit-Harm Analysis.
    Ann Intern Med. 2019 Sep 17. pii: 2751452. doi: 10.7326/M19-1132.
    >> Share

    August 2019
  69. KATZ D, Gavin MC
    Stable Ischemic Heart Disease.
    Ann Intern Med. 2019;171:ITC17-ITC32.
    >> Share

    July 2019
  70. RANASINGHE I, Labrosciano C, Horton D, Ganesan A, et al
    Institutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation: A Cohort Study.
    Ann Intern Med. 2019 Jul 30. pii: 2739788. doi: 10.7326/M18-2810.
    >> Share

  71. O'BRIEN CW, Juraschek SP, Wee CC
    Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease in the United States: Results From the 2017 National Health Interview Survey.
    Ann Intern Med. 2019 Jul 23. pii: 2738925. doi: 10.7326/M19-0953.
    >> Share

  72. VALLABHAJOSYULA S, Bell MR
    Immediate and delayed coronary angiography did not differ for survival after OHCA without STEMI.
    Ann Intern Med. 2019;171:JC4.
    >> Share

  73. PANAGIOTOU OA, Kumar A, Gutman R, Keohane LM, et al
    Hospital Readmission Rates in Medicare Advantage and Traditional Medicare: A Retrospective Population-Based Analysis.
    Ann Intern Med. 2019;171:99-106.
    >> Share

  74. KHAN SU, Khan MU, Riaz H, Valavoor S, et al
    Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes: An Umbrella Review and Evidence Map.
    Ann Intern Med. 2019 Jul 9. pii: 2737825. doi: 10.7326/M19-0341.
    >> Share

  75. YEBYO HG, Aschmann HE, Puhan MA
    Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2019;171:74-76.
    >> Share

  76. DJULBEGOVIC B, Hozo I
    Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2019;171:73-74.
    >> Share

  77. ZHOU Z
    Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2019;171:73.
    >> Share

  78. SPENCE JD
    Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2019;171:72-73.
    >> Share

  79. SORUM PC
    Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2019;171:74.
    >> Share

  80. GOOD CB, Hernandez I, Parekh N
    Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2019;171:72.
    >> Share

    June 2019
  81. MERLI GJ, Weitz HH
    Web Exclusive. Annals Consult Guys - Length of Stay After Myocardial Infarction: How Low Can We Go?
    Ann Intern Med. 2019;170:CG1.
    >> Share

  82. CENTOR RM, Blaha MJ
    Web Exclusive. Annals On Call - Coronary Artery Calcium Testing.
    Ann Intern Med. 2019;170:OC1.
    >> Share

  83. BATES ER
    After an acute coronary syndrome, alirocumab reduced total nonfatal CV events and deaths vs placebo.
    Ann Intern Med. 2019;170:JC62.
    >> Share

  84. KIRSCHNER JM, Hunter BR
    In normoxemic suspected MI, oxygen therapy did not reduce all-cause mortality or HF hospitalization at 2 years.
    Ann Intern Med. 2019;170:JC63.
    >> Share

  85. COHEN JB, Lotito MJ, Trivedi UK, Denker MG, et al
    Cardiovascular Events and Mortality in White Coat Hypertension: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2019 Jun 11. pii: 2735719. doi: 10.7326/M19-0223.
    >> Share

  86. GRUNDY SM, Stone NJ
    2018 Cholesterol Clinical Practice Guidelines: Synopsis of the 2018 American Heart Association/American College of Cardiology/Multisociety Cholesterol Guideline.
    Ann Intern Med. 2019;170:779-783.
    >> Share

    May 2019
  87. MERLI GJ, Weitz HH
    Web Exclusive. Annals Consult Guys - Cardiovascular Risk, Blood Pressure, and Cognition in a Patient With Diabetes.
    Ann Intern Med. 2019;170:CG1.
    >> Share

  88. SCHECTMAN JM
    Review: In adults, general health checks do not reduce all-cause, cardiovascular, or cancer mortality.
    Ann Intern Med. 2019;170:JC52.
    >> Share

    April 2019
  89. BRAND A, Gao L, Hamann A, Crayen C, et al
    Medical Graphic Narratives to Improve Patient Comprehension and Periprocedural Anxiety Before Coronary Angiography and Percutaneous Coronary Intervention: A Randomized Trial.
    Ann Intern Med. 2019 Apr 9. pii: 2730521. doi: 10.7326/M18-2976.
    >> Share

    March 2019
  90. AVIV A
    Clonal Hematopoiesis Confers Predisposition to Both Cardiovascular Disease and Cancer.
    Ann Intern Med. 2019;170:356.
    >> Share

  91. O'GLASSER AY
    Regarding Marcia.
    Ann Intern Med. 2019;170:346-347.
    >> Share

    February 2019
  92. SELAK V, Jackson R, Poppe K, Wu B, et al
    Predicting Bleeding Risk to Guide Aspirin Use for the Primary Prevention of Cardiovascular Disease: A Cohort Study.
    Ann Intern Med. 2019 Feb 26. pii: 2726667. doi: 10.7326/M18-2808.
    >> Share

  93. LU J, Lu Y, Yang H, Bilige W, et al
    Characteristics of High Cardiovascular Risk in 1.7 Million Chinese Adults.
    Ann Intern Med. 2019 Feb 19. pii: 2725144. doi: 10.7326/M18-1932.
    >> Share

  94. WHELTON PK, Colantonio LD
    Cardiovascular Disease Risk Estimation in China.
    Ann Intern Med. 2019 Feb 19. pii: 2725146. doi: 10.7326/M18-3301.
    >> Share

  95. BELL KJL, Doust J, Glasziou P, Cullen L, et al
    Recognizing the Potential for Overdiagnosis: Are High-Sensitivity Cardiac Troponin Assays an Example?
    Ann Intern Med. 2019;170:259-261.
    >> Share

  96. KAZI DS, Penko J, Coxson PG, Guzman D, et al
    Cost-Effectiveness of Alirocumab: A Just-in-Time Analysis Based on the ODYSSEY Outcomes Trial.
    Ann Intern Med. 2019;170:221-229.
    >> Share

  97. CARDOSO R, Nasir K, Blumenthal RS, Blaha MJ, et al
    Selective Use of Coronary Artery Calcium Testing for Shared Decision Making: Guideline Endorsed and Ready for Prime Time.
    Ann Intern Med. 2019 Feb 12. pii: 2724340. doi: 10.7326/M18-3675.
    >> Share

    January 2019
  98. JORGE A, Wallace ZS, Lu N, Zhang Y, et al
    Renal Transplantation and Survival Among Patients With Lupus Nephritis: A Cohort Study.
    Ann Intern Med. 2019 Jan 22. pii: 2722549. doi: 10.7326/M18-1570.
    >> Share

  99. MERLI GJ, Weitz HH
    Web Exclusive. Annals Consult Guys - Low Risk for Postoperative Myocardial Infarction: What Do We Really Know?
    Ann Intern Med. 2019;170:CG1.
    >> Share

  100. GOODMAN M, Getahun D, Silverberg MJ, Safer J, et al
    Cross-Sex Hormones and Acute Cardiovascular Events in Transgender Persons.
    Ann Intern Med. 2019;170:143.
    >> Share

  101. GOLDSTEIN Z, Streed C, Resiman T, Mukherjee M, et al
    Cross-Sex Hormones and Acute Cardiovascular Events in Transgender Persons.
    Ann Intern Med. 2019;170:142-143.
    >> Share

  102. FURLAN S, Borzak S
    After PCI with 2nd-generation DESs for STEMI, dual-antiplatelet therapy for 6 mo was noninferior to 12 mo.
    Ann Intern Med. 2019;170:JC6.
    >> Share

  103. SULLIVAN K, Van Spall HGC
    A wearable cardioverter-defibrillator did not reduce arrhythmic death in MI with reduced ejection fraction.
    Ann Intern Med. 2019;170:JC5.
    >> Share

  104. THOMAS NJ
    Physician, Heal Thyself.
    Ann Intern Med. 2019;170:135.
    >> Share

  105. KAUFMAN TM, Fazio S, Shapiro MD
    Brief Commentary: Marijuana and Cardiovascular Disease-What Should We Tell Patients?
    Ann Intern Med. 2019 Jan 8. pii: 2720158. doi: 10.7326/M18-3009.
    >> Share

    December 2018
  106. HUDSON MP
    Coronary CTA reduced risk for coronary events at 5 years in patients with stable chest pain.
    Ann Intern Med. 2018;169:JC70.
    >> Share

  107. GILBERT MP, Bain SC, Franek E, Jodar-Gimeno E, et al
    Effect of Liraglutide on Cardiovascular Outcomes in Elderly Patients: A Post Hoc Analysis of a Randomized Controlled Trial.
    Ann Intern Med. 2018 Dec 4. pii: 2717732. doi: 10.7326/M18-1569.
    >> Share

  108. YEBYO HG, Aschmann HE, Puhan MA
    Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease: A Modeling Study.
    Ann Intern Med. 2018 Dec 4. pii: 2717730. doi: 10.7326/M18-1279.
    >> Share


  109. Benefits and Harms of Using Statins to Prevent Cardiovascular Disease.
    Ann Intern Med. 2018 Dec 4. pii: 2717123. doi: 10.7326/P18-0019.
    >> Share

    November 2018
  110. BATES ER
    Review: In coronary artery disease, PCI reduces 30-day and 5-year risk for stroke compared with CABG.
    Ann Intern Med. 2018;169:JC55.
    >> Share

  111. SMITH DA
    Review: In adults, increasing omega-6 fatty acid intake does not reduce mortality or overall cardiovascular events.
    Ann Intern Med. 2018;169:JC51.
    >> Share

  112. SMITH DA
    Review: Long-chain omega-3 fatty acids have no effect on mortality or overall cardiovascular events.
    Ann Intern Med. 2018;169:JC50.
    >> Share

  113. CENTOR RM, Hayward RA
    Web Exclusive. Annals On Call - Improving Estimation of Cardiovascular Risk.
    Ann Intern Med. 2018;169:OC1.
    >> Share

  114. DEVEREAUX PJ
    The Potential for Troponin to Inform Prognosis in Patients With Stable Coronary Artery Disease.
    Ann Intern Med. 2018 Nov 6. pii: 2712931. doi: 10.7326/M18-2984.
    >> Share

  115. HAMMADAH M, Kim JH, Tahhan AS, Kindya B, et al
    Use of High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia: A Cohort Study.
    Ann Intern Med. 2018 Nov 6. pii: 2712482. doi: 10.7326/M18-0670.
    >> Share

    October 2018
  116. GROSSO G, Sippl N, Kjellstrom B, Amara K, et al
    Antiphospholipid Antibodies in Patients With Myocardial Infarction.
    Ann Intern Med. 2018 Oct 23. pii: 2709123. doi: 10.7326/M18-2130.
    >> Share

    August 2018

  117. Effects of a Mediterranean-Style Diet on Cardiovascular Risk Factors.
    Ann Intern Med. 2018;169:270-271.
    >> Share

  118. MAI LM, Oczkowski W
    Tenecteplase before thrombectomy for ischemic stroke improved reperfusion compared with alteplase.
    Ann Intern Med. 2018;169:JC20.
    >> Share

    July 2018
  119. LIU P, Dhruva SS, Shah ND, Ross JS, et al
    Medicare Beneficiary Out-of-Pocket Costs for Generic Cardiovascular Medications Available Through $4 Generic Drug Discount Programs.
    Ann Intern Med. 2018 Jul 24. pii: 2694805. doi: 10.7326/M18-0965.
    >> Share

  120. GETAHUN D, Nash R, Flanders WD, Baird TC, et al
    Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study.
    Ann Intern Med. 2018 Jul 10. pii: 2687653. doi: 10.7326/M17-2785.
    >> Share

  121. STUART JJ, Tanz LJ, Missmer SA, Rimm EB, et al
    Hypertensive Disorders of Pregnancy and Maternal Cardiovascular Disease Risk Factor Development: An Observational Cohort Study.
    Ann Intern Med. 2018 Jul 3. pii: 2686987. doi: 10.7326/M17-2740.
    >> Share

  122. FRASER A
    Women's Cardiovascular Health After a Hypertensive Disorder of Pregnancy.
    Ann Intern Med. 2018 Jul 3. pii: 2686988. doi: 10.7326/M18-1443.
    >> Share


  123. High Blood Pressure During Pregnancy and Development of Risk Factors for Cardiovascular Disease.
    Ann Intern Med. 2018 Jul 3. pii: 2686989. doi: 10.7326/P18-0008.
    >> Share

    June 2018
  124. BATES ER
    Review: In CAD, CABG reduced 5-year mortality more than PCI in multivessel but not left main disease.
    Ann Intern Med. 2018;168:JC66.
    >> Share

  125. DEFILIPPIS AP, Trainor P
    When Given a Lemon, Make Lemonade: Revising Cardiovascular Risk Prediction Scores.
    Ann Intern Med. 2018 Jun 5. pii: 2683614. doi: 10.7326/M18-1175.
    >> Share

  126. YADLOWSKY S, Hayward RA, Sussman JB, McClelland RL, et al
    Clinical Implications of Revised Pooled Cohort Equations for Estimating Atherosclerotic Cardiovascular Disease Risk.
    Ann Intern Med. 2018 Jun 5. pii: 2683613. doi: 10.7326/M17-3011.
    >> Share

    May 2018
  127. EBERT BL, Libby P
    Clonal Hematopoiesis Confers Predisposition to Both Cardiovascular Disease and Cancer: A Newly Recognized Link Between Two Major Killers.
    Ann Intern Med. 2018 May 29. pii: 2683000. doi: 10.7326/M18-0737.
    >> Share

  128. STAMATELOPOULOS K, Mueller-Hennessen M, Georgiopoulos G, Sachse M, et al
    Amyloid-beta (1-40) and Mortality in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Cohort Study.
    Ann Intern Med. 2018 May 22. pii: 2681795. doi: 10.7326/M17-1540.
    >> Share

  129. GOEL A
    Efficacy and safety of ticagrelor were similar in patients with past MI, regardless of multivessel coronary disease.
    Ann Intern Med. 2018;168:JC56.
    >> Share

  130. PERZYNSKI AT, Rothberg MB, Dawson NV, Coulton CJ, et al
    Accuracy of Cardiovascular Risk Prediction Varies by Neighborhood Socioeconomic Position.
    Ann Intern Med. 2018;168:681-682.
    >> Share

  131. SPENCE JD
    Accuracy of Cardiovascular Risk Prediction Varies by Neighborhood Socioeconomic Position.
    Ann Intern Med. 2018;168:680-681.
    >> Share

    April 2018
  132. CHAMBERLAIN JJ, Johnson EL, Leal S, Rhinehart AS, et al
    Cardiovascular Disease and Risk Management: Review of the American Diabetes Association Standards of Medical Care in Diabetes 2018.
    Ann Intern Med. 2018 Apr 3. pii: 2677350. doi: 10.7326/M18-0222.
    >> Share

    March 2018
  133. BROWN AF, Liang LJ, Vassar SD, Escarce JJ, et al
    Trends in Racial/Ethnic and Nativity Disparities in Cardiovascular Health Among Adults Without Prevalent Cardiovascular Disease in the United States, 1988 to 2014.
    Ann Intern Med. 2018 Mar 20. pii: 2675356. doi: 10.7326/M17-0996.
    >> Share

  134. MENSAH GA
    The Black-White Cardiovascular Health Disparity Is Narrowing, But Not for the Reason You Think.
    Ann Intern Med. 2018 Mar 20. pii: 2675357. doi: 10.7326/M18-0349.
    >> Share

    February 2018
  135. GRANT PJ, Eagle KA
    Annals for Hospitalists Inpatient Notes - Perioperative Medicine-The Past, Present, and Future of Cardiovascular Risk Assessment and Risk Reduction Strategies.
    Ann Intern Med. 2018;168:HO2-HO3.
    >> Share

    January 2018
  136. RAVI D, Ghasemiesfe M, Korenstein D, Cascino T, et al
    Associations Between Marijuana Use and Cardiovascular Risk Factors and Outcomes: A Systematic Review.
    Ann Intern Med. 2018 Jan 23. pii: 2670319. doi: 10.7326/M17-1548.
    >> Share

  137. MANCINI GBJ
    Comparison Shopping: Guidelines for Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2018 Jan 2. pii: 2667697. doi: 10.7326/M17-2917.
    >> Share

    December 2017
  138. LIPSCOMBE LL
    Exenatide did not reduce major cardiovascular outcomes in type 2 diabetes.
    Ann Intern Med. 2017;167:JC67.
    >> Share

  139. SUNDARARAJAN V, Vogrin S
    Comparative Effectiveness of Routine Invasive Coronary Angiography for Managing Unstable Angina.
    Ann Intern Med. 2017;167:836.
    >> Share

  140. OSHIMA Y, Morishima Y, Ono K, Hirano M, et al
    Comparative Effectiveness of Routine Invasive Coronary Angiography for Managing Unstable Angina.
    Ann Intern Med. 2017;167:836.
    >> Share

  141. KOPIN L, Lowenstein C
    Dyslipidemia.
    Ann Intern Med. 2017;167:ITC81-ITC96.
    >> Share

    November 2017
  142. O'DONOGHUE FJ, McDonald CF
    Review: In obstructive sleep apnea, continuous positive airway pressure does not reduce cardiovascular outcomes.
    Ann Intern Med. 2017;167:JC55.
    >> Share

  143. O'DONOGHUE FJ, McDonald CF
    Review: In adults with sleep apnea, positive airway pressure does not reduce cardiovascular events or death.
    Ann Intern Med. 2017;167:JC54.
    >> Share

  144. PICCOLO R, Windecker S
    Low-Dose Aspirin to Reduce the Risk for Myocardial Infarction Among Patients With Coronary Stents Undergoing Noncardiac Surgery.
    Ann Intern Med. 2017 Nov 14. doi: 10.7326/M17-2954.
    >> Share

  145. GRAHAM MM, Sessler DI, Parlow JL, Biccard BM, et al
    Aspirin in Patients With Previous Percutaneous Coronary Intervention Undergoing Noncardiac Surgery.
    Ann Intern Med. 2017 Nov 14. doi: 10.7326/M17-2341.
    >> Share

  146. NIEUWSMA JA, Williams JW Jr, Namdari N, Washam JB, et al
    Diagnostic Accuracy of Screening Tests and Treatment for Post-Acute Coronary Syndrome Depression: A Systematic Review.
    Ann Intern Med. 2017 Nov 14. doi: 10.7326/M17-1811.
    >> Share

  147. DAVIDSON KW, Wasson LT, Kronish IM
    Should You Screen for and Manage Depression in Patients With a Recent Acute Coronary Syndrome? Evidence-Based Answers.
    Ann Intern Med. 2017 Nov 14. doi: 10.7326/M17-2831.
    >> Share

  148. GO AS, Singer DE, Toh S, Cheetham TC, et al
    Outcomes of Dabigatran and Warfarin for Atrial Fibrillation in Contemporary Practice: A Retrospective Cohort Study.
    Ann Intern Med. 2017 Nov 14. doi: 10.7326/M16-1157.
    >> Share

  149. ZHANG XL, Zhu QQ, Kang LN, Li XL, et al
    Mid- and Long-Term Outcome Comparisons of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2017;167:642-654.
    >> Share

    October 2017

  150. Correction: Rapid Rule-out of Acute Myocardial Infarction With a Single High-Sensitivity Cardiac Troponin T Measurement Below the Limit of Detection.
    Ann Intern Med. 2017;167:528.
    >> Share

    September 2017
  151. DHARMARAJAN K, McNamara RL, Wang Y, Masoudi FA, et al
    Age Differences in Hospital Mortality for Acute Myocardial Infarction: Implications for Hospital Profiling.
    Ann Intern Med. 2017 Sep 26. doi: 10.7326/M16-2871.
    >> Share

  152. BAKER DW
    Age-Related Differences in Hospital Quality of Care for Acute Myocardial Infarction: Getting to the Heart of the Matter.
    Ann Intern Med. 2017 Sep 26. doi: 10.7326/M17-2363.
    >> Share

  153. QUINN T
    Review: Real-world use of nonsteroidal antiinflammatory drugs is associated with acute myocardial infarction.
    Ann Intern Med. 2017;167:JC30.
    >> Share

  154. WORSTER A, Kavsak P
    4 hs-cTnI algorithms had high sensitivity and low failure rates for ruling out acute MI in the ED.
    Ann Intern Med. 2017;167:JC35.
    >> Share

  155. WORSTER A, Kavsak P
    High-STEACS Algorithm missed fewer patients with acute MI than the ESC Pathway in the ED.
    Ann Intern Med. 2017;167:JC34.
    >> Share

  156. LOWENSTERN A, Newby LK
    In PCI-treated ACS, switching from aspirin + a newer P2Y12 blocker to aspirin + clopidogrel reduced adverse events.
    Ann Intern Med. 2017;167:JC28.
    >> Share

    August 2017
  157. RYMER JA, Granger CB
    Review: A single hs-cTnT with a cutpoint < limit of detection plus a nonischemic ECG can rule out acute MI.
    Ann Intern Med. 2017;167:JC23.
    >> Share

    July 2017
  158. SCHATTNER A
    Patients with new-onset rheumatoid arthritis had increased risk for ischemic and nonischemic heart failure.
    Ann Intern Med. 2017;167:JC8.
    >> Share

    April 2017
  159. KUSSMAUL III WG
    The Single High-Sensitivity Serum Cardiac Troponin Level: A Significant Advance for Chest Pain Pathways?
    Ann Intern Med. 2017 Apr 18. doi: 10.7326/M17-0919.
    >> Share

    February 2017
  160. BATES ER
    In left main CAD, PCI with everolimus-eluting stents was noninferior to CABG for death, MI, or stroke at 3 years.
    Ann Intern Med. 2017;166:JC21.
    >> Share

  161. BATES ER
    In left main CAD, CABG reduced major adverse cardiac or cerebrovascular events at 5 years compared with PCI.
    Ann Intern Med. 2017;166:JC20.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016